Advances in Pharmacologic Therapies for Type 2 Diabetes.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0302-8
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2013 AND VI 15 AND IP 2
Results: 8
1
2
Does the Benefit from Statin Therapy Extend Beyond 5 Years?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0297-1
- By:
- Publication type:
- Article
3
The Evolution or Revolution of Statin Therapy in Primary Prevention: Where Do We Go From Here?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0298-0
- By:
- Publication type:
- Article
4
Imaging of Vulnerable Plaques Using Near-Infrared Spectroscopy for Risk Stratification of Atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0304-6
- By:
- Publication type:
- Article
5
Statins and Diabetes: The Good, the Bad, and the Unknown.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0299-z
- By:
- Publication type:
- Article
6
Pharmacologic Interactions of Multidrug Therapy for Dyslipidemia.
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0303-7
- By:
- Publication type:
- Article
7
Is the Future of Statins Aligned with New Novel Lipid Modulation Therapies?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0300-x
- By:
- Publication type:
- Article
8
Do the Frequencies of Adverse Events Increase, Decrease, or Stay the Same with Long-Term Use of Statins?
- Published in:
- Current Atherosclerosis Reports, 2013, v. 15, n. 2, p. 1, doi. 10.1007/s11883-012-0301-9
- By:
- Publication type:
- Article